Yamazaki Tomoyuki, Akimoto Tetsu, Iwazu Yoshitaka, Sugase Taro, Takeshima Eri, Numata Akihiko, Komada Takanori, Yoshizawa Hiromichi, Otani Naoko, Morishita Yoshiyuki, Saito Osamu, Takemoto Fumi, Muto Shigeaki, Kusano Eiji, Nagata Daisuke
Division of Nephrology, Department of Internal Medicine, Jichi Medical School, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
CEN Case Rep. 2015 May;4(1):106-111. doi: 10.1007/s13730-014-0148-8. Epub 2014 Oct 2.
Bleeding from the gastrointestinal tract is one of the common determinants of morbidity and mortality in the ordinary clinical setting. The gastrointestinal involvement of Henoch-Schönlein purpura (HSP) has often been described as self-limiting, with no long-term morbidity. In this report, we describe our experience with a male HSP patient who presented with abdominal pain, loss of appetite and deteriorated renal function associated with nephrotic syndrome. Despite the use of aggressive immunomodulatory treatments, including corticosteroids and plasmapheresis, he developed lethal gastrointestinal hemorrhage. We believe that the accumulation of more experience with additional cases similar to ours is mandatory for the establishment of optimal management for HSP patients with severe gastrointestinal manifestations.
胃肠道出血是普通临床环境中发病率和死亡率的常见决定因素之一。过敏性紫癜(HSP)的胃肠道受累通常被描述为自限性,不会导致长期发病。在本报告中,我们描述了一名男性HSP患者的病例,该患者出现腹痛、食欲不振以及与肾病综合征相关的肾功能恶化。尽管采用了积极的免疫调节治疗,包括使用皮质类固醇和血浆置换,但他仍发生了致命的胃肠道出血。我们认为,积累更多与我们类似病例的经验对于为有严重胃肠道表现的HSP患者制定最佳治疗方案至关重要。